Indication
Colorectal Cancer with Liver Metastasis
4 clinical trials
5 products
1 drug
Product
NKR-2Clinical trial
An Open-label Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal CancerStatus: Terminated, Estimated PCD: 2018-01-15
Clinical trial
Phase II Open Label Trial of Thermal Ablation and Lyso-Thermosensitive Liposomal Doxorubicin (Thermodox) for Metastatic Colorectal Cancer (mCRC) Liver LesionsStatus: Terminated, Estimated PCD: 2013-05-01
Product
ThermoDoxClinical trial
Biospecimen Collection for:Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver MetastasesStatus: Recruiting, Estimated PCD: 2024-07-01
Product
Icosapent EthylClinical trial
Influence of Argipressin on Blood Loss During Hepatic Resection; a Double-blinded, Randomized Placebo-controlled Trial (ARG-01)Status: Recruiting, Estimated PCD: 2024-12-01
Product
ArgipressinDrug
Varlilumab